Drug class
Streptogramin antibacterial combination; protein-synthesis inhibitor
Mechanism of action
Contains synergistic streptogramin components that bind distinct sites on the 50S ribosomal subunit, inhibiting peptide-chain elongation and producing bactericidal activity against susceptible Gram-positive bacteria.
General use cases
- Treatment of selected skin, soft-tissue and respiratory infections caused by susceptible Gram-positive bacteria, including certain resistant staphylococci, in countries where pristinamycin is authorised; current availability and antimicrobial susceptibility must be checked
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
